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 MULTIPLATE CAN BE USED TO DETECT INCREASED PLATELET REACTIVITY IN DOGS WITH DISEASES 
KNOWN TO PREDISPOSE FOR HYPERCOAGULABILITY AND THROMBOSIS.  
 
1CB Marschner, 1AT Kristensen, 1EH Spodsberg, 1LR Jessen, 2B Wiinberg, 1Faculty of Health and 
Medical Sciences, University of Copenhagen, Denmark, 2Novo Nordisk A/S, Maaloev, Denmark. 
 
There are few diagnostic laboratory methods available for evaluation of platelet function and 
contribution to thrombotic events in the clinical setting. The impedance whole blood platelet 
aggregometer Multiplate® has recently become available. Although it is being marketed for 
monitoring effect of antiplatelet therapy, it can also be used for assessment of platelet aggregation 
in response to various agonists, reflecting platelet function, activity and reactivity in response to 
disease. The purpose of this study was therefore to investigate Multiplate® as a diagnostic tool for 
detection of variations in platelet aggregation in dogs with diseases known to predispose to 
hypercoagulability and thrombosis and to evaluate whether there is a correlation  between 
Multiplate aggregation response and the maximal amplitude (MA) measured by 
thromboelastography (TEG). 
Twenty clinically healthy dogs and eighteen diseased dogs with neoplasia, generalized 
inflammation or protein losing enteropathy or -nephropathy admitted to the University Hospital for 
Companion Animals, University of Copenhagen, were included in the study. Citrated and 
heparinised blood samples were collected. Multiplate® aggregations were performed on diluted 
heparinised whole blood for 12 minutes using ADP, Collagen (COL) and Arachidonic Acid (AA) as 
agonists and NaCl as buffer control. Results were recorded as area under the curve (AUC). Dilute 
(1:50000) Tissue Factor TEG analyses were performed on citrated whole blood.   
Diseased dogs had significantly increased AUC compared to healthy dogs for NaCl buffer control 
(p=0.0005), ADP (p<0.0001) and COL (p=0.0048) whereas no significant difference was obtained 
for AA as agonist (p=0.3116). TEG-MA was significantly higher (p=0.0114) in diseased dogs 
compared to healthy dogs. A significant correlation was not found between TEG-MA and 
Multiplate AUC using ADP (p=0.1720, r=-0.3366), COL (p=0.2274, r=-0.2994) or AA (p=0.4304, 
r=-0.1982).  
These results demonstrate that Multiplate® aggregation responses are significantly increased in a 
population of diseased dogs with diseases known to predispose to hypercoagulability and 
thrombosis, but results are not significantly correlated to TEG-MA. This suggests that the 
Multiplate method can be used to detect increased platelet reactivity in dogs with diseases known to 
predispose for hypercoagulability and thrombosis and that Multiplate provides additional 
information on platelet function than TEG alone in this patient group. Further studies are needed to 
determine how Multiplate and TEG-MA results correlate to thrombosis and whether there may be 
an added benefit of using them in combination. 
